![James F. Howard, Jr., MD](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/08/efgartigimod-found-to-improve-symptoms-of-patients-with-generalized-myasthenia-gravis-image2-scaled-1-600x750.jpeg)
May 10, 2022
UCB Presents Efficacy, Safety Results for Zilucoplan, Rozanolixizumab for Generalized Myasthenia Gravis
James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health in the UNC School of Medicine, was lead investigator in the Phase 3 clinical trial of zilucoplan.